Cynata Partners with Leading Biologic Product Manufacturer |
Cynata Therapeutics Ltd announced that it has signed a manufacturing agreement with Waisman Biomanufacturing under which Waisman will undertake manufacturing process development, scale-up and clinical-grade manufacture of Cynata’s proprietary Cymerus™ off-the-shelf stem cell product. [Cynata Therapeutics Ltd]
Parcell Laboratories Promotes Colin White, Ph.D., to Chief Scientific Officer
Parcell Laboratories, Inc., developer of novel therapeutics based on its patented adult stem cell platform technology, the ELA® cell, has promoted Colin White, Ph.D., to the newly-created position of chief scientific officer. [Marketwire L.P.]
Ampio Announces Positive Preliminary Biochemical Findings from the Synovial Fluid of the Knees Treated in the SPRING Study
Ampio Pharmaceuticals, Inc. announced preliminary biochemical analysis of samples of synovial fluid drawn from the index knee (treated knee) of a subset of patients who participated in the SPRING study. This synovial analysis, suggested by the FDA, tests the change in expression of signaling and structural proteins that arise from the treatment of the knee with either AmpionTM or the saline vehicle control. [Ampio Pharmaceuticals Inc.]
From our sponsor: Learn about assays for cord blood. Download the free technical bulletin.
Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!
Comments or Suggestions? Submit your feedback here.